Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

3rd Annual Stability Testing Conference

Next-Gen Sequencing Trends 2009

Competitor Analysis: c-MET/HGF Inhibitors

The Japanese Pharmaceutical Market 2008-2023

New Products

Japanese Pharmaceutical Market 2009-2024

3rd Annual Lyophilisation Conference

The Global Bioinformatics Market: Market size, forecasts and company profiles

Pharmaceutical Mergers and Acquisitions (PH133)

Pharmaceutical Speaker Programs (PH134) Measuring ROI and Communicating Value

Strategic Clinical Sourcing (PH125)) Managing Costs and CROs

The Global Analgesics Market 2009-2024

Competitor Analysis: Coagulation Factors

Competitor Analysis: PDGF-R Agonists and Antagonists

World Market for Addiction Disorders, 2009-2016

BioPortfolio | Urch Publishing Reports | Manufacturing in the Global Pharmaceuticals Industry Key drivers, company strategies and regulations (3rd Edition)

Manufacturing in the Global Pharmaceuticals Industry Key drivers, company strategies and regulations (3rd Edition)

The new edition of this best-selling report offers insight into the manufacturing process, strategy, issues and drivers from an expert author.

Manufacturing in the Global Pharmaceuticals Industry - Key drivers, company strategies and regulations (3rd ed) is the only report available that covers this crucial area of the pharmaceutical industry in such depth. The concentration in recent years on creating organisations that are market or customer-led, or research-driven has taken the focus away from the manufacturing process, although it is clear that the most successful organisations integrate all these activities to remain market leaders.

Global pharmaceutical manufacturing is in a state of flux. There is excess capacity in manufacturing facilities for finished dosage forms and a shortfall for biotechnology manufacturing. The situation in APIs is not so clear-cut, and the trend for multinationals to grow through M & A has led to the need to rationalise facilities. Meanwhile, local companies from emerging markets wishing to expand into new markets and exporting must be able to satisfy ever more stringent quality standards.

This report tackles the challenges of manufacturing in a global marketplace by providing unique insight into the strategies a successful company will adopt. By using examples, case studies and scenarios to aid clarification of the more technical aspects of the manufacturing process, you can be assured your desisions are made with full understanding of the key issues.

This timely third edition will enable you to:

* Assess the pros and cons of outsourcing manufacturing functions and develop key strategies to effectively measure supplier and contractor performance

* Understand and prepare for the latest regulations applicable to manufacturing and their variations globally

* Develop strategies to effectively manage contractor relationships

* Understand the definitions used in validation, and how extra investment in validation will improve performance

* Build competencies for manufacturing that meet the objectives of: speed of delivery, reduction in product cost, overall quality, optimisation of capital spend, maintenance of customer inventory, minimisation of regulatory impact, optimisation in the number of manfacturing sites, maintenance of strategic sourcing for disaster management planning

* Understand the 'New Paradigm' in international manufacturing and how it relates to the pharmaceutical industry.

Use this report help with:

# Planning a global manfacturing strategy

# Regulations and quality assurance issues

# The 'New Paradigm' in manufacturing

# The key drivers and changes in today's manufacturing environment

# Making the right investment decision

Publication date: September 2008

ISBN: 978-1-905751-09-9

Pages: 135

Format: PDF
Table of Contents
Price: $1,410.00 / €943.29

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions